千亿·国际(中国)唯一官方网站
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2025.03.28
千亿国际:董事会对独立董事独立性评估的专项意见
2025.03.28
千亿国际:第三期员工持股计划(修订稿)摘要
2025.03.28
千亿国际:第三期员工持股计划(修订稿)
2025.03.28
千亿国际:第二期员工持股计划(修订稿)摘要
2025.03.28
千亿国际:第二期员工持股计划(修订稿)
2025.03.28
千亿国际:2024年年度审计报告
2025.03.28
千亿国际:2024年年度报告摘要
2025.03.28
千亿国际:2024年度商誉减值测试报告
2025.03.28
千亿国际:2024年度监事会工作报告
2025.03.28
千亿国际:2024年年度报告
第一页
上一页
2
3
4
5
6
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.